S4327-119 A Bill To Require Regulatory Review Of Pharmaceutical Products From Chinese Entities, And For Other Purposes.

Sponsor: Cotton, Tom, AR

Representative for undefined's undefinedth district. undefined.

A bill summary has not yet been created for this bill.

Likes

Dislikes

Bill Timeline

  1. Introduced

    Introduced in Senate

  2. Referred

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Comments

Committees

ActivityCommittee
Referred ToSenate Health, Education, Labor, and Pensions Committee

This bill's main subject is: Health

Source:Congress.gov

Bill Cosponsors

There are no official cosponsors listed on this bill.

Related Legislation

Browse all bills
HRES1223-119
Expressing support for the designation of Undiagnosed Awareness Month.
REFERRED
HR8521-119
Protect Moms From Domestic Violence Act
REFERRED
HR8430-119
Federal and State Food Safety Information Sharing Act of 2026
REFERRED
HR8429-119
Baby Food Safety Act of 2026
REFERRED
HR8432-119
To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.
REFERRED
HR8431-119
Third-Party Certification and Inspection Modernization Act of 2026
REFERRED

Frequently Asked Questions

What is S4327-119 about?

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

Who sponsored S4327-119?

Sponsored by Cotton, Tom.

When was S4327-119 introduced?

S4327-119 was introduced on April 16, 2026.

What is the current status of S4327-119?

Current status: REFERRED.